ES8401926A1 - Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. - Google Patents

Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.

Info

Publication number
ES8401926A1
ES8401926A1 ES517995A ES517995A ES8401926A1 ES 8401926 A1 ES8401926 A1 ES 8401926A1 ES 517995 A ES517995 A ES 517995A ES 517995 A ES517995 A ES 517995A ES 8401926 A1 ES8401926 A1 ES 8401926A1
Authority
ES
Spain
Prior art keywords
formula
hydroxybenzylamino
preparing
same
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517995A
Other languages
English (en)
Spanish (es)
Other versions
ES517995A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES517995A0 publication Critical patent/ES517995A0/es
Publication of ES8401926A1 publication Critical patent/ES8401926A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
ES517995A 1981-12-14 1982-12-07 Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias. Expired ES8401926A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33054281A 1981-12-14 1981-12-14

Publications (2)

Publication Number Publication Date
ES517995A0 ES517995A0 (es) 1984-01-16
ES8401926A1 true ES8401926A1 (es) 1984-01-16

Family

ID=23290219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517995A Expired ES8401926A1 (es) 1981-12-14 1982-12-07 Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.

Country Status (8)

Country Link
EP (1) EP0081782B1 (en:Method)
JP (1) JPS58109452A (en:Method)
AT (1) ATE16278T1 (en:Method)
CA (1) CA1219587A (en:Method)
DE (1) DE3267188D1 (en:Method)
DK (1) DK552682A (en:Method)
ES (1) ES8401926A1 (en:Method)
GR (1) GR77088B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2262524A (en) * 1991-12-18 1993-06-23 Sandoz Ltd Pharmaceutically active 2-hydroxy-benzylamines
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
NZ304291A (en) * 1995-03-14 1999-01-28 Novartis Ag Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
TW436483B (en) * 1997-08-19 2001-05-28 Otsuka Pharma Co Ltd Carbostyril derivatives, process for their preparation and pharmaceutical composition or cosmetic composition for inhibiting skin erythema and/or skin pigmentation
AU2002222683B9 (en) 2000-12-18 2021-12-23 Institute Of Medicinal Molecular Design, Inc Inflammatory cytokine release inhibitor
CA2487891A1 (en) * 2002-06-05 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Inhibitors against the activation of ap-1 and nfat
TW200406198A (en) 2002-06-06 2004-05-01 Inst Med Molecular Design Inc O-substituted hydroxyaryl derivatives
CA2488367A1 (en) 2002-06-06 2003-12-18 Institute Of Medicinal Molecular Design, Inc. Antiallergic agents
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784138A (en) * 1953-03-07 1957-03-05 Bayer Ag Fungicidal compositions of nu-arylhydroxyarylmethylamines
AT332863B (de) * 1973-01-02 1976-10-25 Gerot Pharmazeutika Verfahren zur herstellung von neuen 2-aminomethyl-4,6-dihalogenphenolderivaten sowie deren additionssalzen mit sauren

Also Published As

Publication number Publication date
EP0081782B1 (en) 1985-10-30
DK552682A (da) 1983-06-15
EP0081782A1 (en) 1983-06-22
DE3267188D1 (en) 1985-12-05
ES517995A0 (es) 1984-01-16
JPS58109452A (ja) 1983-06-29
GR77088B (en:Method) 1984-09-06
CA1219587A (en) 1987-03-24
ATE16278T1 (de) 1985-11-15

Similar Documents

Publication Publication Date Title
ES8604487A1 (es) Un metodo para preparar derivados de alcanoles aromaticos policiclicos
ES8204428A1 (es) Procedimiento para preparar alfa-aril-1h-1,2,4-triazol-1- etanoles
ES8601170A1 (es) Procedimiento para la preparacion de nuevos derivados tiazolidinicos
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
GB921547A (en) Derivatives of 2-hydroxy-5,9-dimethyl-6,7-benzomorphane, their salts, and process for their production
ES8704905A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta (d) pirimidina.
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8301926A1 (es) Un procedimiento para la preparacion de un compuesto
ES8201582A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES8607982A1 (es) Un procedimiento para preparar un derivado de uridina
ES8801666A1 (es) Un procedimiento para la prepracion de derivados de acidos griseolicos.
ES8304145A1 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
ES8404851A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES8702905A1 (es) Un procedimiento para preparar derivados de alcanoles hete- ropoliciclicos
ES8303424A1 (es) Procedimiento para la obtencion de esteres del acido 7b-(2-(2-animo-4-tiazolil)-2-(sin)-metoxiimino-acetamido)-3-cefem-4-caboxilico.
ES8305349A1 (es) "procedimiento para la fabricacion de derivados de las (tienil-2) y (tienil-3)-2 etilaminas".
ES448509A1 (es) Mejoras en el procedimiento de preparacion de derivados fluordeshidroxilados de alcoholes organicos.
ES8704901A1 (es) Un procedimiento para la preparacion de arilquinolonas 7- sustituidas
ES8802063A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
ES8504795A1 (es) Un procedimiento para obtener 2,5-anhidro-3,4,6-tri-o-acil-d-alonselenocarboxamida
ES265738A1 (es) Un procedimiento para la preparaciën de un dinitrato de alcohileno diol
ES8200692A1 (es) Procedimiento para la preparacion de nuevas cefalosporinas